Reduced plasma levels of Copine 5 correlate with sepsis-induced vascular leakage and mortality in human patients and a murine sepsis model - Scorecard - MDSpire
Advertisement
Reduced plasma levels of Copine 5 correlate with sepsis-induced vascular leakage and mortality in human patients and a murine sepsis model
Clinical Scorecard: Lowered plasma concentrations of Copine 5 are associated with vascular leakage and increased mortality in sepsis patients and a murine model of sepsis
At a Glance
Category
Detail
Condition
Sepsis with vascular leakage and organ dysfunction
Key Mechanisms
Loss of endothelial barrier integrity leading to vascular hyperpermeability; reduced Copine 5 (CPNE5) expression correlates with endothelial dysfunction
Target Population
Adult patients with sepsis admitted to intensive care units
Care Setting
Intensive Care Units (ICU) and research laboratory settings
Key Highlights
Sepsis causes life-threatening organ dysfunction via dysregulated host response including hyper-inflammation and immunosuppression.
Endothelial barrier disruption and vascular leakage are early pathophysiological events linked to sepsis severity and mortality.
Copine 5 (CPNE5) is predominantly expressed in aortic endothelial cells and lowered plasma CPNE5 levels associate with increased vascular leakage and mortality in sepsis.
Guideline-Based Recommendations
Diagnosis
Consider measuring plasma biomarkers related to endothelial injury such as CPNE5, syndecan-1 (SDC-1), Angiopoietin-II (Ang-II), and soluble ICAM-1 (sICAM-1) for prognostic evaluation in sepsis.
Recognize the heterogeneity of sepsis presentations and the limitations of current biomarkers in accurately predicting outcomes.
Management
Early adequate antimicrobial therapy and hemodynamic support remain essential in sepsis management.
Further research is needed before CPNE5-targeted therapies can be recommended.
Monitoring & Follow-up
Monitor plasma levels of endothelial injury markers including CPNE5 to assess vascular leakage and predict sepsis progression.
Regular clinical assessment of organ function and hemodynamic status in ICU patients with sepsis.
Risks
High mortality risk (30–50%) persists despite current management due to complex host responses and endothelial dysfunction.
Failure of immunomodulatory agents in improving sepsis outcomes highlights need for novel biomarkers and therapeutic targets.
Patient & Prescribing Data
Adult ICU patients diagnosed with sepsis exhibiting endothelial injury
Current treatments focus on infection control and hemodynamic support; CPNE5 levels may serve as a prognostic biomarker but no direct treatment targeting CPNE5 is established.
Clinical Best Practices
Incorporate assessment of endothelial injury biomarkers to improve prognostic accuracy in sepsis.
Maintain vigilance for early signs of vascular leakage and organ dysfunction in septic patients.
Support ongoing research into CPNE5 and other novel biomarkers to enhance understanding and management of sepsis.
